Vamikibart in Participants With Uveitic Macular Edema

Clinical trial NCT05642325 · COMPLETED

Trial details

NCT number: NCT05642325
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uveitic Macular Edema

Start date: 2023-03-23
Primary completion: 2025-05-07
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.